AN2 Therapeutics (ANTX) Preferred Dividend Payments (2021 - 2022)
AN2 Therapeutics' (ANTX) quarterly Preferred Dividend Payments came in at $1.8 million in Q1 2022, up 139.16% year-on-year from $761000.0 in Q1 2021, and down 5.45% on a QoQ basis from $1.9 million in Q4 2021.
AN2 Therapeutics (ANTX) Preferred Dividend Payments (2021 - 2022) Analysis & Trends
AN2 Therapeutics (ANTX) has 2 years of Preferred Dividend Payments data on file, last reported at $1.8 million in Q1 2022.
- On a quarterly basis, Preferred Dividend Payments rose 139.16% year-over-year to $1.8 million in Q1 2022; TTM through Dec 2022 was $1.8 million, a 72.06% decrease from a year earlier, with the FY2022 full-year figure at $1.8 million, down 72.06% from the prior year.
- Preferred Dividend Payments for Q1 2022 stood at $1.8 million, down from $1.9 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for ANTX reached as high as $1.9 million in Q3 2021 and fell as low as $761000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AN2 Therapeutics | 167.57 Mn | 167.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.82 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.93 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 761,000.00 |